Cédric Turpinat

ORCID: 0000-0001-6225-3327
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cerebrovascular and Carotid Artery Diseases
  • Renal and Vascular Pathologies
  • Genomics and Rare Diseases
  • Alzheimer's disease research and treatments
  • Congenital Heart Disease Studies
  • Trace Elements in Health
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiovascular and Diving-Related Complications
  • Acute Ischemic Stroke Management
  • Cardiovascular Syncope and Autonomic Disorders
  • Genetic Associations and Epidemiology
  • Amyloidosis: Diagnosis, Treatment, Outcomes

Université de Montpellier
2023-2024

Inserm
2024

Centre Hospitalier Universitaire de Montpellier
2021-2023

Hôpital Gui de Chauliac
2019-2021

Hôpital Saint Eloi
2021

Early detection of brain amyloidosis (Aβ+) is pivotal for diagnosing Alzheimer's disease (AD) and optimizing patient management, especially in light emerging treatments. While plasma biomarkers are promising, their combined diagnostic value through specific ratios remains underexplored. To evaluate the accuracy pTau isoform (pTau181 pTau217) to Aβ42 detecting Aβ+ status. This study included 423 participants from multicenter prospective ALZAN cohort, recruited cognitive complaints. status was...

10.1101/2024.12.07.24318640 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2024-12-08
Coming Soon ...